Senescence of hematopoietic progenitor cells, enforced by the BRAFV600E mutation, underlies the development of Langerhans cell histiocytosis and could be a new target for drug development and therapy of this disease in patients.
- Camille Bigenwald
- Jessica Le Berichel
- Miriam Merad